Featured in this month’s Master Investor Magazine. Often, a company can have an exciting product in the pipeline for years and remain relatively unnoticed until some kind of catalyst grabs the attention of the market and sends the share price rocketing. No-one has a crystal ball, but more often than not in these cases, such…
I have been a bull of British Land (BLND) ordinary shares because of quantitative easing – first in the UK and US, and much more recently in the Euro area. Now that it is scripted that QE is to taper in the short to medium term in the US and UK, property shares will lose…
I last looked at Advanced Oncotherapy (AVO) back in the Spreadbet Magazine days, having identified them as part of a crop of “speculative small caps that could be set to surprise on the upside in 2015”. Well, certainly haven’t disappointed in that regard, having soared from around 4p at the time of my original article…
By Matthew Heywood of Spreadex Trading AIM stocks is a great way to invest in smaller companies that have the potential to provide significant earnings growth. AIM stocks also come with a number of tax incentives including Venture Capital Trusts, Enterprise Investment Schemes, Business Property Relief and the more familiar ISAs. However, one takes a…
There is an old saying that ridiculously overvalued shares can get even more ridiculously overvalued. Competitive markets may be perfect (the theory that public knowledge permeates every corner of the public domain) but those who buy and sell shares know they are far from perfect in the everyday meaning of the word. Greggs which was…
Barclays Bank (BARC) saw a 60% fall in underlying earnings in the year to 31st December 2013, which was modestly and partly recovered with a 13% increase in earnings last year to 31st December 2014. The company has recently produced its Q1 results to 31st March 2015. So what do they tell us about its…
The first quarter results and statement from GSK has a biblical flavour. We are exalted to raise our gaze unto the hills from which cometh our salvation; which the regulators less poetically translate as future and forward statements. It was an occasion for a transcendental gazing into the future because the Q1 results were not…
Technically interesting perhaps but still very highly price on near term earnings estimates. My last words on this magnificently highly valued share (the share price was then 3,088p) amounted to a question: “A chart worth inspection; a potential momentum buy?” Well now we know the answer! There was momentum but as it turned out, it…
It was a mere fifty days or so ago – yes, as little time as that – when I last looked, mesmerised, into the captivating gaze of pure speculation; the eyes of the cobra. I refer of course to my late February views on Ladbrokes (LAD), the once proud owners of Hilton Hotels, now reduced…
BP’s first quarter results come from a rather battered company that looks (in my imagination) a bit like one of those destroyers returning to port at early dawn, having encountered Captain Lansdorff’s pocket battleship the “Admiral Graff Spee”, at the mouth of the River Plate all those years ago. Its superstructure is in a sorry…
